Copyright Reports & Markets. All rights reserved.

Global Minimal Residual Disease Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Minimal Residual Disease Testing by Type
    • 1.3.1 Overview: Global Minimal Residual Disease Testing Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Minimal Residual Disease Testing Consumption Value Market Share by Type in 2024
    • 1.3.3 Flow Cytometry
    • 1.3.4 Polymerase Chain Reaction
  • 1.4 Global Minimal Residual Disease Testing Market by Application
    • 1.4.1 Overview: Global Minimal Residual Disease Testing Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals and Specialty Clinics
    • 1.4.3 Diagnostic Laboratories
    • 1.4.4 Academic and Research Institutes
    • 1.4.5 Others
  • 1.5 Global Minimal Residual Disease Testing Market Size & Forecast
  • 1.6 Global Minimal Residual Disease Testing Market Size and Forecast by Region
    • 1.6.1 Global Minimal Residual Disease Testing Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Minimal Residual Disease Testing Market Size by Region, (2020-2031)
    • 1.6.3 North America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
    • 1.6.6 South America Minimal Residual Disease Testing Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Minimal Residual Disease Testing Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Adaptive Biotechnologies
    • 2.1.1 Adaptive Biotechnologies Details
    • 2.1.2 Adaptive Biotechnologies Major Business
    • 2.1.3 Adaptive Biotechnologies Minimal Residual Disease Testing Product and Solutions
    • 2.1.4 Adaptive Biotechnologies Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Adaptive Biotechnologies Recent Developments and Future Plans
  • 2.2 ArcherDX
    • 2.2.1 ArcherDX Details
    • 2.2.2 ArcherDX Major Business
    • 2.2.3 ArcherDX Minimal Residual Disease Testing Product and Solutions
    • 2.2.4 ArcherDX Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 ArcherDX Recent Developments and Future Plans
  • 2.3 ARUP Laboratories
    • 2.3.1 ARUP Laboratories Details
    • 2.3.2 ARUP Laboratories Major Business
    • 2.3.3 ARUP Laboratories Minimal Residual Disease Testing Product and Solutions
    • 2.3.4 ARUP Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 ARUP Laboratories Recent Developments and Future Plans
  • 2.4 Asuragen
    • 2.4.1 Asuragen Details
    • 2.4.2 Asuragen Major Business
    • 2.4.3 Asuragen Minimal Residual Disease Testing Product and Solutions
    • 2.4.4 Asuragen Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Asuragen Recent Developments and Future Plans
  • 2.5 F. Hoffmann-La Roche
    • 2.5.1 F. Hoffmann-La Roche Details
    • 2.5.2 F. Hoffmann-La Roche Major Business
    • 2.5.3 F. Hoffmann-La Roche Minimal Residual Disease Testing Product and Solutions
    • 2.5.4 F. Hoffmann-La Roche Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.6 Guardant Health
    • 2.6.1 Guardant Health Details
    • 2.6.2 Guardant Health Major Business
    • 2.6.3 Guardant Health Minimal Residual Disease Testing Product and Solutions
    • 2.6.4 Guardant Health Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Guardant Health Recent Developments and Future Plans
  • 2.7 Labcorp
    • 2.7.1 Labcorp Details
    • 2.7.2 Labcorp Major Business
    • 2.7.3 Labcorp Minimal Residual Disease Testing Product and Solutions
    • 2.7.4 Labcorp Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Labcorp Recent Developments and Future Plans
  • 2.8 NeoGenomics Laboratories
    • 2.8.1 NeoGenomics Laboratories Details
    • 2.8.2 NeoGenomics Laboratories Major Business
    • 2.8.3 NeoGenomics Laboratories Minimal Residual Disease Testing Product and Solutions
    • 2.8.4 NeoGenomics Laboratories Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 NeoGenomics Laboratories Recent Developments and Future Plans
  • 2.9 Sysmex Corporation
    • 2.9.1 Sysmex Corporation Details
    • 2.9.2 Sysmex Corporation Major Business
    • 2.9.3 Sysmex Corporation Minimal Residual Disease Testing Product and Solutions
    • 2.9.4 Sysmex Corporation Minimal Residual Disease Testing Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sysmex Corporation Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Minimal Residual Disease Testing Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Minimal Residual Disease Testing by Company Revenue
    • 3.2.2 Top 3 Minimal Residual Disease Testing Players Market Share in 2024
    • 3.2.3 Top 6 Minimal Residual Disease Testing Players Market Share in 2024
  • 3.3 Minimal Residual Disease Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Minimal Residual Disease Testing Market: Region Footprint
    • 3.3.2 Minimal Residual Disease Testing Market: Company Product Type Footprint
    • 3.3.3 Minimal Residual Disease Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Minimal Residual Disease Testing Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Minimal Residual Disease Testing Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Minimal Residual Disease Testing Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Minimal Residual Disease Testing Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
  • 6.2 North America Minimal Residual Disease Testing Market Size by Application (2020-2031)
  • 6.3 North America Minimal Residual Disease Testing Market Size by Country
    • 6.3.1 North America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
    • 6.3.2 United States Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Minimal Residual Disease Testing Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
  • 7.2 Europe Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
  • 7.3 Europe Minimal Residual Disease Testing Market Size by Country
    • 7.3.1 Europe Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 7.3.3 France Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Minimal Residual Disease Testing Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Minimal Residual Disease Testing Market Size by Region
    • 8.3.1 Asia-Pacific Minimal Residual Disease Testing Consumption Value by Region (2020-2031)
    • 8.3.2 China Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 8.3.5 India Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
  • 9.2 South America Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
  • 9.3 South America Minimal Residual Disease Testing Market Size by Country
    • 9.3.1 South America Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Minimal Residual Disease Testing Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Minimal Residual Disease Testing Market Size by Country
    • 10.3.1 Middle East & Africa Minimal Residual Disease Testing Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Minimal Residual Disease Testing Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Minimal Residual Disease Testing Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Minimal Residual Disease Testing Market Drivers
  • 11.2 Minimal Residual Disease Testing Market Restraints
  • 11.3 Minimal Residual Disease Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Minimal Residual Disease Testing Industry Chain
  • 12.2 Minimal Residual Disease Testing Upstream Analysis
  • 12.3 Minimal Residual Disease Testing Midstream Analysis
  • 12.4 Minimal Residual Disease Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Minimal Residual Disease Testing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

    This report is a detailed and comprehensive analysis for global Minimal Residual Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Minimal Residual Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Minimal Residual Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Minimal Residual Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Minimal Residual Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Minimal Residual Disease Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Minimal Residual Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive Biotechnologies, ArcherDX, ARUP Laboratories, Asuragen, F. Hoffmann-La Roche, Guardant Health, Labcorp, NeoGenomics Laboratories, Sysmex Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Minimal Residual Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Flow Cytometry
    Polymerase Chain Reaction
    Market segment by Application
    Hospitals and Specialty Clinics
    Diagnostic Laboratories
    Academic and Research Institutes
    Others
    Market segment by players, this report covers
    Adaptive Biotechnologies
    ArcherDX
    ARUP Laboratories
    Asuragen
    F. Hoffmann-La Roche
    Guardant Health
    Labcorp
    NeoGenomics Laboratories
    Sysmex Corporation
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Minimal Residual Disease Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Minimal Residual Disease Testing, with revenue, gross margin, and global market share of Minimal Residual Disease Testing from 2020 to 2025.
    Chapter 3, the Minimal Residual Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Minimal Residual Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Minimal Residual Disease Testing.
    Chapter 13, to describe Minimal Residual Disease Testing research findings and conclusion.

    Buy now